Original Article

Awareness and Indications of 5-α-Reductase Inhibitors for Benign Prostatic Hyperplasia in the Primary Care Setting

Objective: The objective of the study was to investigate primary care physicians’ (PCPs’) level of awareness and indications for urology referral in patients treated with 5-α-reductase inhibitors (5-ARIs). Methods: An anonymous 14-question survey was e-mailed to PCPs in the specialties of Family Medicine and Internal Medicine at an academic institution….

Posted in: primary health care 3 prostate cancer 7 prostate-specific antigen 3

Review Article

Beyond PSA: Managing Modern Therapeutic Options in Metastatic Castration-Resistant Prostate Cancer

Prostate cancer remains a significant cause of cancer-related deaths in men in the United States. Significant advances in the treatment of metastatic castration-resistant prostate cancer have been made in recent years with the arrival of new therapeutic targets and options. The definition of progression of disease must be thought of…

Posted in: prostate-specific antigen 3

Original Article

Effects of Commercially Available Soy Products on PSA in Androgen-Deprivation-Naïve and Castration-Resistant Prostate Cancer

Objective: No standard therapeutic option exists for men with prostate cancer who have failed local therapy, have no gross metastatic disease, and whose only manifestation of disease is a rising prostate-specific antigen (PSA) level. Soy products are able to affect PSA kinetics in some men with prostate cancer, and this…

Posted in: prostate cancer 7 prostate-specific antigen 3
SMA Menu